期刊文献+

IL-2的体内分布及其与疗效的关系 被引量:2

Bio-Distribution of IL-2 and Its Relation to the Therapeutic Effects
下载PDF
导出
摘要 本文利用放射性核素Tc-99M标记的IL-2进行IL-2血浆半寿期及其体内分布的研究。结果显示IL-2血浆半寿期仅为10分钟,主要是由于IL-2选择性分布于肝,肾等靶器官,而不是被消除。本文结果显示,IL-2是一高选择性药物,其血浆半寿期很短,而肝,肾等靶器官浓度很高,用于治疗肝肾肿瘤时,具有疗效高而全身毒副作用低的优点。 In this article, the plasma half life of IL-2 and its bio-distribution were studied using radio-nucleus Technetium-99M labeled IL-2. The results showed the plasma half life of IL-2 was merely 10 minutes mainly due to IL-2 distribute to its target organ such as liver, kidney etc,rather than clear out of the body. Our results indicated that IL-2 is a high organ-specific drug. It's plasma half life is short under high concentration in its target organ. So it might have advantages of high effectiveness and low whole body toxicity in treatment of tumor of liver and kidney.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 1996年第4期299-301,共3页 Chinese Journal of Cancer Biotherapy
关键词 IL-2 体内分布 疗效 Tc-99M标记 肝肿瘤 肾肿瘤 interleukin-2 technetium-99M bio-distribution therapeutic effect
  • 相关文献

参考文献1

共引文献5

同被引文献17

  • 1朱铁年,赵瑞景,周学敏,刘文虎,孔月,孙志学.胎脾LAK细胞联合rlL-2治疗癌性胸水临床观察[J].中国肿瘤临床,1995,22(5):325-327. 被引量:3
  • 2Foa R, Guarim A, Gansbacher B. IL -2 treatment for cancer: from biology to therapy[J]. Br J Cancer, 1992,66(4) : 992.
  • 3Maas RA, Dulleus HFJ, Otter WD. Interleukin -2 in cancer treatment : disappointing or (still) promoising? a review[ J ]. Cancer Immunol Immunother ,1993,36(2) :141.
  • 4Astoul P, Viallat J R, Laurent J C, et al. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion[ J].Chest, 1993,103 ( 1 ) : 209.
  • 5Rosenherg SA. A progress report on the treatment of 157 patients with advanced cancer using LAK cellsand rIL - 2 or high - dose of IL-2 alone[J]. V Engl J Med,1987,316(4):889.
  • 6Pizza G, V iza D, Vinci CD, et all. Intra -lymphatic adm instration of interleukin - 2 ( IL - 2 ) in cancer patients : a pilot study[J]. LymphokineRes, 1988,7(1):45.
  • 7Vaage J. Local interleukin -2 therapy ofmouse mammary tumors of various immunogenicities [ J ]. Cancer Res, 1988,48 ( 11 ) : 2193.
  • 8Yasumoto K, Mivazaki K, Nagashima A, et aL Induction of lymphokine - activated killer cells by intrapleural instillations of recombinant interleukin -2 in patients with malignant pleurisy due to lung cancer[ J]. Cancer Res, 1987,47(8) : 2184.
  • 9Ratto G B, Melioli G, Zino P, et al. Immunotherapy with the use of tumor - infiltrating lymphocytes and interleukin - 2 as adjuvant treatment in stage Ⅲ non - small - cell lung cancer. A pilot study[J]. J Thorac Cardiovasc Surg,1995,109(6) : 1212.
  • 10程爱明,李金陵,梁克理,刘风枝.重组白介素-2治疗癌性胸腔积液疗效及NK细胞活性观察[J].中国肿瘤临床,1997,24(10):781-782. 被引量:2

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部